Skip to main content
. 2020 Feb 11;323(6):527–537. doi: 10.1001/jama.2020.0103

Figure 1. Patient Recruitment, Randomization, and Flow Through the CAMERA2 Trial.

Figure 1.

aPatients could have more than 1 reason for exclusion.

bIncludes when a patient’s surrogate decision maker was unavailable, site was not approved for surrogate consent, or interpreters and/or investigators were unavailable.

cInitial rapid test result was called methicillin-resistant Staphylococcus aureus (MRSA) but final laboratory antimicrobial susceptibility test result was methicillin-susceptible S aureus.